Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP29-02 nasal spray vs placebo, azelastine, and fluticasone in seasonal allergic rhinitis
2011-001371-39Phase 3
- Sponsor
- Meda
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of azelastine + fluticasone in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Meda. Primary endpoint: 12-hour reflective Total Nasal Symptom Score (TNSS).
02
Drugs
azelastine + fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2011-001371-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001371-39.